Company / FCF Margin
Catalyst Pharmaceuticals Partners, Inc. FCF Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
35.4%
FY2025
5-year range
35.4% / 54.2%
FY2021-FY2025
Trend
-27.2%
vs FY2024
Sector context
#11 of 135
Health Care
What the data says
Among 135 Health Care companies, Catalyst Pharmaceuticals Partners, Inc. is in the top 8% for fcf margin. FCF Margin has fluctuated over the past 8 years, ranging from -5247.9% in FY2018 to 54.2% in FY2022.
Based on SEC 10-K filings.
35.4% in FY2025 with a 5-year CAGR of -2.4%. Top quartile in the Health Care sector.
Remained stable around 35.4% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- -18.7pp
- 5-Year Change
- -2.4pp
- 10-Year Change
- -
Sector benchmark
Top 8% in Health CareTop 8% of 135This company 35.4% Sector average -680.1%
▼
+105.2% above sector average
Key checks
Key Insights
- In FY2025, fcf margin decreased 27.2% year-over-year.
- Currently 715.5pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2022.
- Lowest fcf margin in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 35.4% | -27.2% |
| FY2024 | 48.6% | +35.1% |
| FY2023 | 36.0% | -33.5% |
| FY2022 | 54.2% | +28.5% |
| FY2021 | 42.1% | +11.5% |
| FY2020 | 37.8% | +11.8% |
| FY2019 | 33.8% | +100.6% |
| FY2018 | -5247.9% | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026